{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:56:41Z","timestamp":1784055401353,"version":"3.55.0"},"publisher-location":"Cham","reference-count":128,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319559469","type":"print"},{"value":"9783319559476","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-55947-6_8","type":"book-chapter","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T06:53:51Z","timestamp":1496127231000},"page":"143-167","source":"Crossref","is-referenced-by-count":6,"title":["Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures"],"prefix":"10.1007","author":[{"given":"Nisha","family":"Kanwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Done","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"key":"8_CR1","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr2333","volume":"11","author":"B Aktas","year":"2009","unstructured":"Aktas B, Tewes M, Fehm T et al (2009) Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res BCR 11:R46","journal-title":"Breast Cancer Res BCR"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm.3915","volume":"21","author":"AA Alizadeh","year":"2015","unstructured":"Alizadeh AA, Aranda V, Bardelli A et al (2015) Toward understanding and exploiting tumor heterogeneity. Nat Med 21:846\u2013853","journal-title":"Nat Med"},{"key":"8_CR3","doi-asserted-by":"crossref","unstructured":"Andreopoulou E, Yang L-Y, Rangel KM et al (2012) Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select\/Detect\u2122 versus Veridex CellSearch\u2122 system. Int J Cancer 130:1590\u20131597","DOI":"10.1002\/ijc.26111"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/ng.669","volume":"42","author":"AC Antoniou","year":"2010","unstructured":"Antoniou AC, Wang X, Fredericksen ZS et al (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor\u2013negative breast cancer in the general population. Nat Genet 42:885\u2013892","journal-title":"Nat Genet"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","volume":"31","author":"I Baccelli","year":"2013","unstructured":"Baccelli I, Schneeweiss A, Riethdorf S et al (2013) Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31:539\u2013544","journal-title":"Nat Biotechnol"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr2224","volume":"11","author":"M Barcellos-Hoff","year":"2009","unstructured":"Barcellos-Hoff M, Akhurst RJ (2009) Transforming growth factor-\u03b2 in breast cancer: too much, too late. Breast Cancer Res 11:202","journal-title":"Breast Cancer Res"},{"key":"8_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molonc.2010.08.002","volume":"5","author":"J Bayani","year":"2011","unstructured":"Bayani J, Marrano P, Graham C et al (2011) Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas. Mol Oncol 5:48\u201360","journal-title":"Mol Oncol"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899\u2013905","journal-title":"Nature"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/annonc\/mdp391","volume":"21","author":"F-C Bidard","year":"2010","unstructured":"Bidard F-C, Mathiot C, Delaloge S et al (2010) Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Annal Oncol Off J Eur Soc Med Oncol\/ESMO 21:729\u2013733","journal-title":"Annal Oncol Off J Eur Soc Med Oncol\/ESMO"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI30740","volume":"117","author":"S Biswas","year":"2007","unstructured":"Biswas S, Guix M, Rinehart C et al (2007) Inhibition of TGF-\u03b2 with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Investig 117:1305\u20131313","journal-title":"J Clin Investig"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1474","volume":"4","author":"CA Borgo\u00f1o","year":"2004","unstructured":"Borgo\u00f1o CA, Diamandis EP (2004) The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4:876\u2013890","journal-title":"Nat Rev Cancer"},{"key":"8_CR12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa050434","volume":"353","author":"S Braun","year":"2005","unstructured":"Braun S, Vogl FD, Naume B et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353:793\u2013802","journal-title":"N Engl J Med"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.4161\/cc.6.19.4914","volume":"6","author":"LL Campbell","year":"2007","unstructured":"Campbell LL, Polyak K (2007) Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle (Georgetown, Tex) 6:2332\u20132338","journal-title":"Cell Cycle (Georgetown, Tex)"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fonc.2014.00201","volume":"4","author":"EL Carpenter","year":"2014","unstructured":"Carpenter EL, Rader J, Ruden J et al (2014) Dielectrophoretic capture and fenetic analysis of single neuroblastoma tumor cells. Front Oncol 4:201","journal-title":"Front Oncol"},{"key":"8_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030992","volume":"7","author":"TR Cawthorn","year":"2012","unstructured":"Cawthorn TR, Moreno JC, Dharsee M et al (2012) Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival. PLoS One 7:e30992","journal-title":"PLoS One"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers AF, Groom AC, MacDonald IC (2002) Metastasis: dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563\u2013572","journal-title":"Nat Rev Cancer"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1210\/me.2010-0368","volume":"25","author":"D Chen","year":"2011","unstructured":"Chen D, Reierstad S, Fang F et al (2011) JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters. Mol Endocrinol 25:767\u2013775","journal-title":"Mol Endocrinol"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781\u2013791","journal-title":"N Engl J Med"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3816\/CBC.2007.n.004","volume":"7","author":"M Cristofanilli","year":"2007","unstructured":"Cristofanilli M, Broglio KR, Guarneri V et al (2007) Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 7:471\u2013479","journal-title":"Clin Breast Cancer"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin S-F et al (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486:346\u2013352","journal-title":"Nature"},{"key":"8_CR21","volume":"9","author":"AE Dago","year":"2014","unstructured":"Dago AE, Stepansky A, Carlsson A et al (2014) Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells. PLoS One 9:e101777","journal-title":"PLoS One"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-07-4756","volume":"14","author":"C Desmedt","year":"2008","unstructured":"Desmedt C, Haibe-Kains B, Wirapati P et al (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 14:5158\u20135165","journal-title":"Clin Cancer Res"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11219","volume":"486","author":"LA Diaz Jr","year":"2012","unstructured":"Diaz LA Jr, Williams RT, Wu J et al (2012) The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486:537\u2013540","journal-title":"Nature"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nature08989","volume":"464","author":"L Ding","year":"2010","unstructured":"Ding L, Ellis MJ, Li S et al (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464:999\u20131005","journal-title":"Nature"},{"key":"8_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015498","volume":"5","author":"D Etemadmoghadam","year":"2010","unstructured":"Etemadmoghadam D, George J, Cowin PA et al (2010) Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer. PLoS One 5:e15498","journal-title":"PLoS One"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/bjc.2011.294","volume":"105","author":"F Farace","year":"2011","unstructured":"Farace F, Massard C, Vimond N et al (2011) A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer 105:847\u2013853","journal-title":"Br J Cancer"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr2349","volume":"11","author":"T Fehm","year":"2009","unstructured":"Fehm T, Hoffmann O, Aktas B et al (2009) Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res BCR 11:R59","journal-title":"Breast Cancer Res BCR"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-010-1163-x","volume":"124","author":"T Fehm","year":"2010","unstructured":"Fehm T, M\u00fcller V, Aktas B et al (2010) HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res Treat 124:403\u2013412","journal-title":"Breast Cancer Res Treat"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1582-4934.2010.01213.x","volume":"15","author":"D-D Feng","year":"2011","unstructured":"Feng D-D, Zhang H, Zhang P et al (2011) Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia. J Cell Mol Med 15:2164\u20132175","journal-title":"J Cell Mol Med"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"16580","DOI":"10.1073\/pnas.1313594110","volume":"110","author":"JC Fischer","year":"2013","unstructured":"Fischer JC, Niederacher D, Topp SA et al (2013) Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients. Proc Natl Acad Sci 110:16580\u201316585","journal-title":"Proc Natl Acad Sci"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.bjc.6605676","volume":"102","author":"LM Flores","year":"2010","unstructured":"Flores LM, Kindelberger DW, Ligon AH et al (2010) Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer. Br J Cancer 102:1495\u20131502","journal-title":"Br J Cancer"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.1073\/pnas.0803304105","volume":"105","author":"JA Foekens","year":"2008","unstructured":"Foekens JA, Sieuwerts AM, Smid M et al (2008) Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 105:13021\u201313026","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883\u2013892","journal-title":"N Engl J Med"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/path.2675","volume":"220","author":"FC Geyer","year":"2010","unstructured":"Geyer FC, Weigelt B, Natrajan R et al (2010) Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 220:562\u2013573","journal-title":"J Pathol"},{"key":"8_CR35","doi-asserted-by":"crossref","unstructured":"Giordano A, Cristofanilli M (2012) CTCs in metastatic breast cancer. Recent Results Cancer Res 195:193\u2013201","DOI":"10.1007\/978-3-642-28160-0_18"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/annonc\/mdq323","volume":"22","author":"A Gradilone","year":"2011","unstructured":"Gradilone A, Naso G, Raimondi C et al (2011) Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Annal Oncol Off J Eur Soc Med Oncol\/ESMO 22:86\u201392","journal-title":"Annal Oncol Off J Eur Soc Med Oncol\/ESMO"},{"key":"8_CR37","doi-asserted-by":"crossref","unstructured":"Harris L, Fritsche H, Mennel R et al (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 25:5287\u20135312","DOI":"10.1200\/JCO.2007.14.2364"},{"key":"8_CR38","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1158\/0008-5472.CAN-12-4140","volume":"73","author":"E Heitzer","year":"2013","unstructured":"Heitzer E, Auer M, Gasch C et al (2013) Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 73:2965\u20132975","journal-title":"Cancer Res"},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/path.3990","volume":"227","author":"L Hernandez","year":"2012","unstructured":"Hernandez L, Wilkerson PM, Lambros MB et al (2012) Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection. J Pathol 227:42\u201352","journal-title":"J Pathol"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ajpath.2012.07.012","volume":"181","author":"K Heselmeyer-Haddad","year":"2012","unstructured":"Heselmeyer-Haddad K, Berroa Garcia LY, Bradley A et al (2012) Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression. Am J Pathol 181:1807\u20131822","journal-title":"Am J Pathol"},{"key":"8_CR41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s13059-014-0453-8","volume":"15","author":"C Hiley","year":"2014","unstructured":"Hiley C, de Bruin EC, McGranahan N et al (2014) Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine. Genome Biol 15:453","journal-title":"Genome Biol"},{"key":"8_CR42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/1078-0432.CCR-09-0709","volume":"16","author":"HM Horlings","year":"2010","unstructured":"Horlings HM, Lai C, Nuyten DSA et al (2010) Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients. Clin Cancer Res 16:651\u2013663","journal-title":"Clin Cancer Res"},{"key":"8_CR43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncb1681","volume":"10","author":"Q Huang","year":"2008","unstructured":"Huang Q, Gumireddy K, Schrier M et al (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10:202\u2013210","journal-title":"Nat Cell Biol"},{"key":"8_CR44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","volume":"13","author":"Y H\u00fcsemann","year":"2008","unstructured":"H\u00fcsemann Y, Geigl JB, Schubert F et al (2008) Systemic spread is an early step in breast cancer. Cancer Cell 13:58\u201368","journal-title":"Cancer Cell"},{"key":"8_CR45","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1158\/1078-0432.CCR-07-4758","volume":"14","author":"M Ignatiadis","year":"2008","unstructured":"Ignatiadis M, Kallergi G, Ntoulia M et al (2008) Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res 14:2593\u20132600","journal-title":"Clin Cancer Res"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/1078-0432.CCR-14-1429","volume":"21","author":"M Jamal-Hanjani","year":"2015","unstructured":"Jamal-Hanjani M, Quezada SA, Larkin J et al (2015) Translational Implications of Tumor Heterogeneity. Clin Cancer Res 21:1258\u20131266","journal-title":"Clin Cancer Res"},{"key":"8_CR47","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.22989","volume":"50","author":"J Ji","year":"2009","unstructured":"Ji J, Yamashita T, Budhu A et al (2009) Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology (Baltimore, MD) 50:472\u2013480","journal-title":"Hepatology (Baltimore, MD)"},{"key":"8_CR48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ijc.29399","volume":"137","author":"N Kanwar","year":"2015","unstructured":"Kanwar N, Hu P, Bedard P et al (2015) Identification of genomic signatures in circulating tumor cells from breast cancer. Int J Cancer 137:332\u2013344","journal-title":"Int J Cancer"},{"key":"8_CR49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nprot.2014.044","volume":"9","author":"NM Karabacak","year":"2014","unstructured":"Karabacak NM, Spuhler PS, Fachin F et al (2014) Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat Protoc 9:694\u2013710","journal-title":"Nat Protoc"},{"key":"8_CR50","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr3099","volume":"14","author":"S Kasimir-Bauer","year":"2012","unstructured":"Kasimir-Bauer S, Hoffmann O, Wallwiener D et al (2012) Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res BCR 14:R15","journal-title":"Breast Cancer Res BCR"},{"key":"8_CR51","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa021153","volume":"347","author":"K Keyomarsi","year":"2002","unstructured":"Keyomarsi K, Tucker SL, Buchholz TA et al (2002) Cyclin E and survival in patients with breast cancer. N Engl J Med 347:1566\u20131575","journal-title":"N Engl J Med"},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","volume":"9","author":"CA Klein","year":"2009","unstructured":"Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302\u2013312","journal-title":"Nat Rev Cancer"},{"key":"8_CR53","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1158\/0008-5472.CAN-08-4586","volume":"69","author":"CA Klein","year":"2009","unstructured":"Klein CA, Stoecklein NH (2009) Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma. Cancer Res 69:5285\u20135288","journal-title":"Cancer Res"},{"key":"8_CR54","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(02)09838-0","volume":"360","author":"CA Klein","year":"2002","unstructured":"Klein CA, Blankenstein TJF, Schmidt-Kittler O et al (2002) Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360:683\u2013689","journal-title":"Lancet"},{"key":"8_CR55","doi-asserted-by":"crossref","unstructured":"Kraan J, Sleijfer S, Strijbos MH et al (2011) External quality assurance of circulating tumor cell enumeration using the CellSearch(\u00ae) system: a feasibility study. Cytometry B Clin Cytom 80:112\u2013118","DOI":"10.1002\/cyto.b.20573"},{"key":"8_CR56","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/cncr.25145","volume":"116","author":"S Krishnamurthy","year":"2010","unstructured":"Krishnamurthy S, Cristofanilli M, Singh B et al (2010) Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer 116:3330\u20133337","journal-title":"Cancer"},{"key":"8_CR57","first-page":"1597","volume":"57","author":"T Kuukasj\u00e4rvi","year":"1997","unstructured":"Kuukasj\u00e4rvi T, Karhu R, Tanner M et al (1997) Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57:1597\u20131604","journal-title":"Cancer Res"},{"key":"8_CR58","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1634\/stemcells.2007-1081","volume":"26","author":"LC Laurent","year":"2008","unstructured":"Laurent LC, Chen J, Ulitsky I et al (2008) Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells 26:1506\u20131516","journal-title":"Stem Cells"},{"key":"8_CR59","first-page":"372","volume":"45","author":"Z-M Li","year":"2010","unstructured":"Li Z-M, Hu S, Xiao L et al (2010) Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780\/Taxol cells. Zhonghua Fu Chan Ke Za Zhi 45:372\u2013375","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"8_CR60","doi-asserted-by":"crossref","unstructured":"Liu MC, Shields PG, Warren RD et al (2009) Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol 27:5153\u20135159","DOI":"10.1200\/JCO.2008.20.6664"},{"key":"8_CR61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nbt.2892","volume":"32","author":"JG Lohr","year":"2014","unstructured":"Lohr JG, Adalsteinsson VA, Cibulskis K et al (2014) Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol 32:479\u2013484","journal-title":"Nat Biotechnol"},{"key":"8_CR62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.24814","volume":"126","author":"J Lu","year":"2010","unstructured":"Lu J, Fan T, Zhao Q et al (2010) Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer 126:669\u2013683","journal-title":"Int J Cancer"},{"key":"8_CR63","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1470-2045(12)70209-7","volume":"13","author":"A Lucci","year":"2012","unstructured":"Lucci A, Hall CS, Lodhi AK et al (2012) Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13:688\u2013695","journal-title":"Lancet Oncol"},{"key":"8_CR64","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/sj.bjc.6600323","volume":"86","author":"L-Y Luo","year":"2002","unstructured":"Luo L-Y, Diamandis EP, Look MP et al (2002) Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance. Br J Cancer 86:1790\u20131796","journal-title":"Br J Cancer"},{"key":"8_CR65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/0008-5472.CAN-11-3017","volume":"73","author":"MJM Magbanua","year":"2012","unstructured":"Magbanua MJM, Sosa EV, Roy R et al (2012) Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res 73:30\u201340","journal-title":"Cancer Res"},{"key":"8_CR66","doi-asserted-by":"crossref","first-page":"E405","DOI":"10.1002\/ijc.26444","volume":"131","author":"RR Mathiesen","year":"2012","unstructured":"Mathiesen RR, Fjelldal R, Liest\u00f8l K et al (2012) High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer. Int J Cancer 131:E405\u2013E415","journal-title":"Int J Cancer"},{"key":"8_CR67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","volume":"27","author":"N McGranahan","year":"2015","unstructured":"McGranahan N, Swanton C (2015) Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27:15\u201326","journal-title":"Cancer Cell"},{"key":"8_CR68","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/2159-8290.CD-12-0222","volume":"2","author":"DT Miyamoto","year":"2012","unstructured":"Miyamoto DT, Lee RJ, Stott SL et al (2012) Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov 2:995\u20131003","journal-title":"Cancer Discov"},{"key":"8_CR69","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI0215234","volume":"109","author":"RS Muraoka","year":"2002","unstructured":"Muraoka RS, Dumont N, Ritter CA et al (2002) Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest 109:1551\u20131559","journal-title":"J Clin Invest"},{"key":"8_CR70","doi-asserted-by":"crossref","unstructured":"Muraoka-Cook RS (2004) Conditional overexpression of active transforming growth factor 1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res 64:9002\u20139011","DOI":"10.1158\/0008-5472.CAN-04-2111"},{"key":"8_CR71","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/bcr3180","volume":"14","author":"R Nadal","year":"2012","unstructured":"Nadal R, Fernandez A, Sanchez-Rovira P et al (2012) Biomarkers characterization of circulating tumour cells in breast cancer patients. Breast Cancer Res BCR 14:R71","journal-title":"Breast Cancer Res BCR"},{"key":"8_CR72","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nature06385","volume":"450","author":"S Nagrath","year":"2007","unstructured":"Nagrath S, Sequist LV, Maheswaran S et al (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235\u20131239","journal-title":"Nature"},{"key":"8_CR73","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/bcr3154","volume":"14","author":"R Natrajan","year":"2012","unstructured":"Natrajan R, Mackay A, Wilkerson PM et al (2012) Functional characterization of the 19q12 amplicon in grade III breast cancers. Breast Cancer Res 14:R53","journal-title":"Breast Cancer Res"},{"key":"8_CR74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1101\/gr.099622.109","volume":"20","author":"N Navin","year":"2010","unstructured":"Navin N, Krasnitz A, Rodgers L et al (2010) Inferring tumor progression from genomic heterogeneity. Genome Res 20:68\u201380","journal-title":"Genome Res"},{"key":"8_CR75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jnci\/djq016","volume":"102","author":"NJ Nelson","year":"2010","unstructured":"Nelson NJ (2010) Circulating tumor cells: will they be clinically useful? J Natl Cancer Inst 102:146\u2013148","journal-title":"J Natl Cancer Inst"},{"key":"8_CR76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13059-015-0657-6","volume":"16","author":"CK Ng","year":"2015","unstructured":"Ng CK, Martelotto LG, Gauthier A et al (2015) Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification. Genome Biol 16:107","journal-title":"Genome Biol"},{"key":"8_CR77","doi-asserted-by":"crossref","first-page":"21083","DOI":"10.1073\/pnas.1320659110","volume":"110","author":"X Ni","year":"2013","unstructured":"Ni X, Zhuo M, Su Z et al (2013) Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci 110:21083\u201321088","journal-title":"Proc Natl Acad Sci"},{"key":"8_CR78","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrc1370","volume":"4","author":"K Pantel","year":"2004","unstructured":"Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4:448\u2013456","journal-title":"Nat Rev Cancer"},{"key":"8_CR79","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329\u2013340","journal-title":"Nat Rev Cancer"},{"key":"8_CR80","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1172\/JCI33295","volume":"117","author":"K Polyak","year":"2007","unstructured":"Polyak K (2007) Breast cancer: origins and evolution. J Clin Invest 117:3155\u20133163","journal-title":"J Clin Invest"},{"key":"8_CR81","volume":"7","author":"AA Powell","year":"2012","unstructured":"Powell AA, Talasaz AH, Zhang H et al (2012) Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 7:e33788","journal-title":"PLoS One"},{"key":"8_CR82","first-page":"3399","volume":"55","author":"DM Radford","year":"1995","unstructured":"Radford DM, Fair KL, Phillips NJ et al (1995a) Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 55:3399\u20133405","journal-title":"Cancer Res"},{"key":"8_CR83","first-page":"5180","volume":"55","author":"DM Radford","year":"1995","unstructured":"Radford DM, Phillips NJ, Fair KL et al (1995b) Allelic loss and the progression of breast cancer. Cancer Res 55:5180\u20135183","journal-title":"Cancer Res"},{"key":"8_CR84","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1593\/neo.07106","volume":"9","author":"F Rashid-Kolvear","year":"2007","unstructured":"Rashid-Kolvear F, Pintilie M, Done SJ (2007) Telomere length on chromosome 17q shortens more than global telomere length in the development of breast cancer. Neoplasia (New York, NY) 9:265\u2013270","journal-title":"Neoplasia (New York, NY)"},{"key":"8_CR85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009485","volume":"5","author":"V Rippe","year":"2010","unstructured":"Rippe V, Dittberner L, Lorenz VN et al (2010) The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS One 5:e9485","journal-title":"PLoS One"},{"key":"8_CR86","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/path.2712","volume":"221","author":"JM Sayagu\u00e9s","year":"2010","unstructured":"Sayagu\u00e9s JM, Abad MM, Melchor HB et al (2010) Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis. J Pathol 221:308\u2013319","journal-title":"J Pathol"},{"key":"8_CR87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2005.08.003","volume":"8","author":"JA Schardt","year":"2005","unstructured":"Schardt JA, Meyer M, Hartmann CH et al (2005) Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8:227\u2013239","journal-title":"Cancer Cell"},{"key":"8_CR88","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1073\/pnas.1331931100","volume":"100","author":"O Schmidt-Kittler","year":"2003","unstructured":"Schmidt-Kittler O, Ragg T, Daskalakis A et al (2003) From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 100:7737\u20137742","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR89","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nature08489","volume":"461","author":"SP Shah","year":"2009","unstructured":"Shah SP, Morin RD, Khattra J et al (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461:809\u2013813","journal-title":"Nature"},{"key":"8_CR90","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah SP, Roth A, Goya R et al (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486:395\u2013399","journal-title":"Nature"},{"key":"8_CR91","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<554::AID-CNCR6>3.0.CO;2-X","volume":"85","author":"KS Shim","year":"1999","unstructured":"Shim KS, Kim KH, Han WS et al (1999) Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection. Cancer 85:554\u2013561","journal-title":"Cancer"},{"key":"8_CR92","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccr.2007.01.013","volume":"11","author":"M Shipitsin","year":"2007","unstructured":"Shipitsin M, Campbell LL, Argani P et al (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11:259\u2013273","journal-title":"Cancer Cell"},{"key":"8_CR93","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1158\/1078-0432.CCR-06-0225","volume":"12","author":"AM Sieuwerts","year":"2006","unstructured":"Sieuwerts AM (2006) Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. Clin Cancer Res 12:3319\u20133328","journal-title":"Clin Cancer Res"},{"key":"8_CR94","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-008-0290-0","volume":"118","author":"AM Sieuwerts","year":"2008","unstructured":"Sieuwerts AM, Kraan J, Bolt-de Vries J et al (2008) Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat 118:455\u2013468","journal-title":"Breast Cancer Res Treat"},{"key":"8_CR95","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1158\/0008-5472.CAN-04-4330","volume":"65","author":"DA Smirnov","year":"2005","unstructured":"Smirnov DA (2005) Global gene expression profiling of circulating tumor cells. Cancer Res 65:4993\u20134997","journal-title":"Cancer Res"},{"key":"8_CR96","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr2568","volume":"12","author":"J Staaf","year":"2010","unstructured":"Staaf J, J\u00f6nsson G, Ringn\u00e9r M et al (2010) High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer. Breast Cancer Res BCR 12:R25","journal-title":"Breast Cancer Res BCR"},{"key":"8_CR97","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/bcr3075","volume":"13","author":"J Staaf","year":"2011","unstructured":"Staaf J, J\u00f6nsson G, Ringn\u00e9r M et al (2011) Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer. Breast Cancer Res BCR 13:R129","journal-title":"Breast Cancer Res BCR"},{"key":"8_CR98","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ijc.24916","volume":"126","author":"NH Stoecklein","year":"2010","unstructured":"Stoecklein NH, Klein CA (2010) Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer 126:589\u2013598","journal-title":"Int J Cancer"},{"key":"8_CR99","doi-asserted-by":"crossref","first-page":"18392","DOI":"10.1073\/pnas.1012539107","volume":"107","author":"SL Stott","year":"2010","unstructured":"Stott SL, Hsu C-H, Tsukrov DI et al (2010) Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 107:18392\u201318397","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1541-7786.MCR-11-0519","volume":"10","author":"MJ Tan","year":"2012","unstructured":"Tan MJ, Teo Z, Sng MK et al (2012) Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer Res MCR 10:677\u2013688","journal-title":"Mol Cancer Res MCR"},{"key":"8_CR101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158354","volume":"11","author":"G Theil","year":"2016","unstructured":"Theil G, Fischer K, Weber E et al (2016) The use of a new cell collector to isolate circulating tumor cells from the blood of patients with different stages of prostate cancer and clinical outcomes \u2013 a proof-of-concept study. PLoS One 11:e0158354","journal-title":"PLoS One"},{"key":"8_CR102","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.celrep.2014.08.029","volume":"8","author":"DT Ting","year":"2014","unstructured":"Ting DT, Wittner BS, Ligorio M et al (2014) Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells. Cell Rep 8:1905\u20131918","journal-title":"Cell Rep"},{"key":"8_CR103","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/onc.2009.489","volume":"29","author":"N Turner","year":"2010","unstructured":"Turner N, Lambros MB, Horlings HM et al (2010) Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene 29:2013\u20132023","journal-title":"Oncogene"},{"key":"8_CR104","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ Vijver van de","year":"2002","unstructured":"van de Vijver MJ, He YD, van\u2019t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999\u20132009","journal-title":"N Engl J Med"},{"key":"8_CR105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.bjc.6605472","volume":"102","author":"I Auwera Van der","year":"2010","unstructured":"Van der Auwera I, Peeters D, Benoy IH et al (2010) Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19\/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 102:276\u2013284","journal-title":"Br J Cancer"},{"key":"8_CR106","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gde.2013.12.004","volume":"24","author":"P Loo Van","year":"2014","unstructured":"Van Loo P, Voet T (2014) Single cell analysis of cancer genomes. Curr Opin Genet Dev 24:82\u201391","journal-title":"Curr Opin Genet Dev"},{"key":"8_CR107","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nature14971","volume":"525","author":"B Waclaw","year":"2015","unstructured":"Waclaw B, Bozic I, Pittman ME et al (2015) A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature 525:261\u2013264","journal-title":"Nature"},{"key":"8_CR108","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature14403","volume":"520","author":"E Wagenblast","year":"2015","unstructured":"Wagenblast E, Soto M, Guti\u00e9rrez-\u00c1ngel S et al (2015) A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature 520:358\u2013362","journal-title":"Nature"},{"key":"8_CR109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/2159-8290.CD-13-0631","volume":"4","author":"N Wagle","year":"2014","unstructured":"Wagle N, Van Allen EM, Treacy DJ et al (2014) MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF\/MEK inhibition. Cancer Discov 4:61\u201368","journal-title":"Cancer Discov"},{"key":"8_CR110","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1101\/gad.1777709","volume":"23","author":"JC Walker","year":"2009","unstructured":"Walker JC, Harland RM (2009) microRNA-24a is required to repress apoptosis in the developing neural retina. Genes Dev 23:1046\u20131051","journal-title":"Genes Dev"},{"key":"8_CR111","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/onc.2009.468","volume":"29","author":"B Wang","year":"2009","unstructured":"Wang B, Hsu S-H, Majumder S et al (2009a) TGF\u03b2-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29:1787\u20131797","journal-title":"Oncogene"},{"key":"8_CR112","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/gcc.20711","volume":"48","author":"C Wang","year":"2009","unstructured":"Wang C, Iakovlev VV, Wong V et al (2009b) Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study. Genes Chromosomes Cancer 48:1091\u20131101","journal-title":"Genes Chromosomes Cancer"},{"key":"8_CR113","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nature13600","volume":"512","author":"Y Wang","year":"2014","unstructured":"Wang Y, Waters J, Leung ML et al (2014) Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512:155\u2013160","journal-title":"Nature"},{"key":"8_CR114","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, van\u2019t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591\u2013602","journal-title":"Nat Rev Cancer"},{"key":"8_CR115","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1097-2765(00)00109-X","volume":"6","author":"JB Weitzman","year":"2000","unstructured":"Weitzman JB, Fiette L, Matsuo K et al (2000) JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell 6:1109\u20131119","journal-title":"Mol Cell"},{"key":"8_CR116","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1600-0463.2008.01033.x","volume":"116","author":"H Wikman","year":"2008","unstructured":"Wikman H, Vessella R, Pantel K (2008) Cancer micrometastasis and tumour dormancy. APMIS 116:754\u2013770","journal-title":"APMIS"},{"key":"8_CR117","first-page":"5679","volume":"63","author":"U Woelfle","year":"2003","unstructured":"Woelfle U, Cloos J, Sauter G et al (2003) Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 63:5679\u20135684","journal-title":"Cancer Res"},{"key":"8_CR118","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0002-9440(10)63026-X","volume":"5","author":"W Wolf","year":"2001","unstructured":"Wolf W, Michael Evans D, Chao L et al (2001) A synthetic tissue kallikrein inhibitor supresses cancer cell invasiveness. Am J Pathol 5:1797\u20131805","journal-title":"Am J Pathol"},{"key":"8_CR119","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000064027","volume":"23","author":"GM Yousef","year":"2002","unstructured":"Yousef GM, Diamandis EP (2002) Expanded human tissue kallikrein family \u2013 a novel panel of cancer biomarkers. Tumour Biol J Int Soc Oncodev Biol Med 23:185\u2013192","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med"},{"key":"8_CR120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cancergencyto.2009.03.017","volume":"193","author":"W Yu","year":"2009","unstructured":"Yu W, Kanaan Y, Bae YK et al (2009) Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet Cytogenet 193:29\u201337","journal-title":"Cancer Genet Cytogenet"},{"key":"8_CR121","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature11217","volume":"487","author":"M Yu","year":"2012","unstructured":"Yu M, Ting DT, Stott SL et al (2012) RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487:510\u2013513","journal-title":"Nature"},{"key":"8_CR122","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580\u2013584","journal-title":"Science"},{"key":"8_CR123","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2015.73","volume":"12","author":"D Zardavas","year":"2015","unstructured":"Zardavas D, Irrthum A, Swanton C et al (2015) Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol 12:381\u2013394","journal-title":"Nat Rev Clin Oncol"},{"key":"8_CR124","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s10620-009-1051-6","volume":"55","author":"H Zhang","year":"2010","unstructured":"Zhang H, Li M, Han Y et al (2010) Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 55:2545\u20132551","journal-title":"Dig Dis Sci"},{"key":"8_CR125","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-12-1587","volume":"18","author":"L Zhang","year":"2012","unstructured":"Zhang L, Riethdorf S, Wu G et al (2012) Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res 18:5701\u20135710","journal-title":"Clin Cancer Res"},{"key":"8_CR126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/etm.2012.750","volume":"5","author":"H Zhang","year":"2013","unstructured":"Zhang H, Wei S, Ning S et al (2013) Evaluation of TGF\u03b2, XPO4, elF5A2 and ANGPTL4 as biomarkers in HCC. Exp Ther Med 5:119\u2013127","journal-title":"Exp Ther Med"},{"key":"8_CR127","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1756-9966-30-55","volume":"30","author":"X Zhao","year":"2011","unstructured":"Zhao X, Yang L, Hu J (2011) Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. J Exp Clin Cancer Res 30:55","journal-title":"J Exp Clin Cancer Res"},{"key":"8_CR128","doi-asserted-by":"crossref","unstructured":"Zhu P, Tan Ming J, Huang R-L et al (2011) Angiopoietin-like 4 protein elevates the prosurvival intracellular O2\u2212:H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 19:401\u2013415","DOI":"10.1016\/j.ccr.2011.01.018"}],"container-title":["Advances in Experimental Medicine and Biology","Isolation and Molecular Characterization of Circulating Tumor Cells"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-55947-6_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T03:24:40Z","timestamp":1569381880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-55947-6_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319559469","9783319559476"],"references-count":128,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-55947-6_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}